loading page

Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic
  • +32
  • Gabriela Villanueva,
  • Claudia Sampor,
  • Julia Palma,
  • Milena Villarroel,
  • Diana Valencia,
  • Mercedes Garcia Lombardi,
  • Wendy Gómez García,
  • Eva Lezcano Caceres,
  • Victoria Sobrero,
  • Lilia Garcia Rodriguez,
  • Victor Cabrera,
  • Ivan Maza,
  • Thelma Velasquez,
  • Cecilia Ugaz,
  • Jacqueline Montoya,
  • Rosdali Diaz Coronado,
  • Natalia Gonzalez,
  • Simone Aguiar,
  • Agustín Dabezies,
  • Florencia Moreno,
  • Susan Sardinas,
  • Yessika Gamboa,
  • ESSY MARADIEGUE,
  • Ligia Fu,
  • Pascale Gassant,
  • Katiuska Moreno,
  • Oscar Gonzalez-Ramella,
  • Magdalena Schelotto,
  • Sandra Luna-Fineman,
  • Celia Antoneli,
  • Soad Fuentes Alabi,
  • Silvana Luciani,
  • Andrea Cappellano,
  • Guillermo Chantada,
  • Liliana Vasquez
Gabriela Villanueva
Austral University Hospital

Corresponding Author:gabrielavillanueva7@gmail.com

Author Profile
Claudia Sampor
Hospital de Pediatría "Prof Dr JPGarrahan"
Author Profile
Julia Palma
Hospital Luis Calvo Mackenna
Author Profile
Milena Villarroel
Hospital Luis Calvo Mackenna
Author Profile
Diana Valencia
IMAT Oncomédica
Author Profile
Mercedes Garcia Lombardi
Ricardo Gutiérrez Children´s Hospital
Author Profile
Wendy Gómez García
Robert Reid Cabral Children's Hospital
Author Profile
Eva Lezcano Caceres
Hospital Central Instituto de Prevision Social
Author Profile
Victoria Sobrero
Hospital Zonal Juan Ramon Carrillo
Author Profile
Lilia Garcia Rodriguez
Centro Universitario contra el Cáncer UANL
Author Profile
Victor Cabrera
Hospital Regional de Rio Blanco
Author Profile
Ivan Maza
Hospital Nacional Edgardo Rebagliati Martins
Author Profile
Thelma Velasquez
Unidad Nacional de Oncologia Pediatrica
Author Profile
Cecilia Ugaz
Instituto Nacional de Enfermedades Neoplasicas
Author Profile
Jacqueline Montoya
Instituto Nacional de Enfermedades Neoplasicas
Author Profile
Rosdali Diaz Coronado
Instituto Nacional de Enfermedades Neoplasicas
Author Profile
Natalia Gonzalez
Hospital Militar Central
Author Profile
Simone Aguiar
Hospital Santa Marcelina
Author Profile
Agustín Dabezies
Pereira Rossell
Author Profile
Florencia Moreno
Registro Onco-pediatrico Hospitalario Argentino (ROHA, Hospital-based Pediatric Cancer Registry from Argentina), Instituto Nacional del Cáncer
Author Profile
Susan Sardinas
Hospital del Niño Dr. Ovidio Aliaga Uría
Author Profile
Yessika Gamboa
Hospital Nacional de Niños
Author Profile
ESSY MARADIEGUE
Instituto Nacional de Enfermedades Neoplasicas
Author Profile
Ligia Fu
Hospital Escuela Universitario
Author Profile
Pascale Gassant
Hôpital Saint - Damien
Author Profile
Katiuska Moreno
Hospital Verdi Cevallos Balda - Hospital especialidades Portoviejo
Author Profile
Oscar Gonzalez-Ramella
Hospital Civil de Guadalajara Dr. Juan I. Menchaca
Author Profile
Magdalena Schelotto
Pereira Rossell Hospital Center
Author Profile
Sandra Luna-Fineman
Children's Hospital Colorado
Author Profile
Celia Antoneli
Universidade Nove the Julhio
Author Profile
Soad Fuentes Alabi
Benjamin Bloom Hospital
Author Profile
Silvana Luciani
Pan American Health Organization
Author Profile
Andrea Cappellano
Instituto de Oncologia Pediátrica - IOP/GRAACC/UNIFESP
Author Profile
Guillermo Chantada
Austral University Hospital
Author Profile
Liliana Vasquez
Pan American Health Organization
Author Profile

Abstract

The ongoing COVID-19 pandemic strained medical systems worldwide. We report on the impact on pediatric oncology care in Latin American (LATAM) during its first year. Four cross-sectional surveys were electronically distributed among pediatric onco-hematologist in April/June/October 2020, and April/2021 through the Latin American Society of Pediatric Oncology (SLAOP) email list and St Jude Global regional partners. 453 pediatric onco-hematologists from 20 countries responded the first survey with subsequent surveys response rates above 85%. More than 95% of participants reported that treatment continued without interruption for new and active on-going patients, though with disruptions in treatment availability. During the first three surveys, respondents reported suspensions of outpatient procedures (54.2%), a decrease in oncologic surgeries (43.6%), radiotherapy (28.4%), stem cell transplants (SCT) (69.3%), and surveillance consultations (81.2%). Logistic regression analysis showed that at the beginning of the first wave, participants from countries with healthcare expenditure below 7% were more likely to report a decrease in outpatient procedures (OR:1.84, 95%C:1.19;2.8), surgeries (OR:3, 95%CI:1.9;4.6) and radiotherapy (OR:6, 95%CI:3.5;10.4). Suspension of surveillance consultations was higher in countries with COVID-19 case fatality rates above 2% (OR:3, 95%CI:1.4;6.2) and SCT suspensions in countries with COVID-19 incidence rate above 100 cases per 100,000 (OR:3.48, 95%CI:1.6;7.45). Paradoxically, at the beginning of the second wave with COVID-19 cases rising exponentially, most participants reported improvements in cancer services availability. Our data show the medium-term collateral effects of the pandemic on pediatric oncology care in LATAM, which might help delineate oncology care delivery amid current and future challenges posed by the pandemic.
23 Jan 2022Submission Checks Completed
23 Jan 2022Assigned to Editor
23 Jan 2022Submitted to Pediatric Blood & Cancer
28 Jan 2022Reviewer(s) Assigned
06 Feb 2022Review(s) Completed, Editorial Evaluation Pending
07 Feb 2022Editorial Decision: Revise Major
23 Mar 20221st Revision Received
23 Mar 2022Submission Checks Completed
23 Mar 2022Assigned to Editor
28 Mar 2022Reviewer(s) Assigned
03 Apr 2022Review(s) Completed, Editorial Evaluation Pending
04 Apr 2022Editorial Decision: Accept
20 May 2022Published in Pediatric Blood & Cancer. 10.1002/pbc.29748